ANTI-HUMAN GLOBULIN (COOMBS) - ANVISA Registration 10154450180

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10154450180 and manufactured by FRESENIUS HEMOCARE BRASIL LTDA.. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Nov 27, 2027.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DIAMED GMBH, ORTHO CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.